Clinical Trial Update: A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 trial update in adults with grass pollen-induced rhinoconjunctivitis; results have been posted after study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinoconjunctivitis

Drugs mentioned

• Grass pollen allergen immunotherapy tablet (Timothy grass pollen extract (Phleum pratense))

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergy | Phase 3 | Status: COMPLETED | Results posted: 2024-12-16